Ontology highlight
ABSTRACT:
Methods: The expression of AMPK?1, AMPK?2 and phosphorylated AMPK? (p-AMPK?) was determined immunohistochemically in 524 formalin-fixed, paraffin-embedded malignant and premalignant cervical tissues. Subsequently, associations with clinicopathological characteristics and patient survival were assessed.
Results: AMPK?2 expression was observed in the cytoplasm and nucleus, while expression of AMPK?1 and p-AMPK? was mainly observed in the cytoplasm. p-AMPK? expression increased during the normal-to-tumor transition of cervical carcinoma (p < 0.001), but, once cancer developed, the expression of AMPK?2 and p-AMPK? decreased in large-sized tumors when compared to smaller tumors (36 vs. 68%, p = 0.004 and 39 vs. 64%, p = 0.029, respectively). Notably, AMPK?2 expression was significantly associated with better disease-free survival (HR 0.29, 95% CI 0.10-0.86, p = 0.026).
Conclusion: The AMPK?2 isoform showed potential as a favorable prognostic marker in cervical cancer. Therefore, additional studies are necessary to further clarify the complex contribution of AMPK isoforms and of phosphorylation status to cervical cancer progression and prognosis.
SUBMITTER: Choi CH
PROVIDER: S-EPMC7722984 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
Choi Chel Hun CH Chung Joon-Yong JY Cho Hanbyoul H Kitano Haruhisa H Chang Eileen E Ylaya Kris K Chung Eun Joo EJ Kim Jae-Hoon JH Hewitt Stephen M SM
Pathobiology : journal of immunopathology, molecular and cellular biology 20150825 5
<h4>Objectives</h4>Cervical cancer is one of the most common gynecological malignancies worldwide, and its association with the AMP-activated protein kinase (AMPK) is still unknown. We aimed to investigate the clinical correlation between AMPK expression and cervical cancer.<h4>Methods</h4>The expression of AMPKα1, AMPKα2 and phosphorylated AMPKα (p-AMPKα) was determined immunohistochemically in 524 formalin-fixed, paraffin-embedded malignant and premalignant cervical tissues. Subsequently, asso ...[more]